"Strategies for Success in Managing
Cancer and Specialty Pharmacy"
October 12, 2016
Special thanks to our sponsors!
AbbVie is a global biopharmaceutical company. We have the passion, focus and capabilities to bring to market groundbreaking science to address some of the world's greatest health challenges.

Bayer: Science For A Better Life 

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2015, the Group employed around 117,000 people and had sales of EUR 46.3 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.3 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to www.bayer.us.
About Oncology at Bayer
Bayer is committed to delivering science for a better life by advancing a portfolio of innovative treatments. The oncology franchise at Bayer now includes three oncology products and several other compounds in various stages of clinical development. Together, these products reflect the company's approach to research, which prioritizes targets and pathways with the potential to impact the way that cancer is treated. 
Cancer Treatment Centers of America is a national hospital system with a collaborative and comprehensive approach to cancer care. We are a destination facility with five hospitals nationally. We work with self-insured employers, brokers and TPAs through direct contracting to ensure their employees/members can access our state-of-the-art, high quality treatments at in-network pricing. All this is delivered through an integrative model where a team of experts puts patients at the center of their own care; we call this Patient Empowered Care.
George Kelly
National Manager, Business Markets
Considered the founder of biotechnology, Genentech has delivered on the promise of biotechnology for over 30 years by discovering, developing, manufacturing and commercializing treatments for serious or life-threatening diseases. Genentech creates novel medicines for cancer, stroke, heart attacks, HIV, influenza, macular degeneration, cystic fibrosis and rheumatoid arthritis. 
Smoking cessation, vaccines, and breast cancer awareness programs. 

Updated 3/29/2018

Strategies for Success - Sponsors